Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
NYSE
$288.24
▼ DOWN 1.12% (-3.26)

KEY STATISTICS

Market Cap$13.89 B
52w High$303.31
52w Low$144.26
Dividend Yield—
Frequency—
P/E29.12
Volume1.09M
Shares Out.48.17M

COMPANY

LEADERSHIP

Birgit Girshick
CHIEF EXECUTIVE
Birgit Girshick

COMPENSATION 2026

Salary$1,461,866
Stock Awards$9,138,724
Incentive Plan Pay$1,130,074
All Other Comp.$71,887
Total$14,096,924

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 23, 2000
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
19,000

PRICE TARGET

Target High$300.00
Target Low$219.00
Target Median$273.00
Target Consensus$267.60

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$958.47M
NOV
4
WED

PRICE

$288.24 ▼ DOWN 1.12% (−$3.26)
$286$288$2909:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM288.24

About Charles River Laboratories International, Inc.

https://www.criver.com ↗

Charles River Laboratories provides global non-clinical drug discovery, safety testing, research models, and manufacturing solutions to support biopharmaceutical research and development.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT CHARLES RIVER LABORATORIES INTERNATIONAL, INC. IS KNOWN FOR

Endosafe® Trillium™ rCR cartridge
Endosafe® Trillium™ rCR cartridge

Charles River offers an animal-free, rapid bacterial endotoxin test using recombinant cascade reagent (rCR) technology, supporting their commitment to sustainable, innovative solutions for the pharmaceutical and medical device industries.

COMPETITORS

COMPETITOR
ICLR COMPARE
IQV COMPARE
LH COMPARE
TMO COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Discovery and Safety Assessment$600.68M $591.57M ▼$596.92M ▲$606.51M ▲
Research Models and Services$213.47M $206.26M ▼$208.37M ▲$209.47M ▲
Manufacturing Support$190.69M $196.4M ▲$190.54M ▼$188.1M ▼

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$537.61M $517.35M ▼$543.81M ▲$539.86M ▼
Europe$277.69M $279.9M ▲$277.58M ▼$263.07M ▼
CANADA$116.81M $123.28M ▲$109.57M ▼$127.51M ▲
Asia Pacific$51.66M $56.91M ▲$55.48M ▼$60.52M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
462
LISTED HERE
26
RANKED BY POSITION SIZE
VTS.AX
0.02% · 1.5M
RSP
0.29% · 1.0M
IVV.AX
0.02% · 642.4K
SPY
0.02% · 591.2K
DFAT
0.36% · 178.4K
XDEW.L
0.29% · 164.4K
SCHM
0.26% · 133.3K
FWD
0.73% · 80.7K
TMSL
0.75% · 76.4K
CGMM
0.58% · 74.3K
FTXH
1.78% · 64.4K
JHMM
0.24% · 51.0K
XHYH
0.41% · 33.0K
FMTM
3.36% · 32.5K
BBH
1.66% · 26.7K
FSMD
0.28% · 24.8K
RECS
0.12% · 24.0K
DOCG.L
1.93% · 21.6K
BBMC
0.29% · 21.5K
INR.PA
0.52% · 19.0K
WSCSRI.SW
0.53% · 15.1K
ZSP.TO
0.02% · 15.1K
VETS
1.43% · 14.9K
EZM
0.36% · 11.8K
GSC
1.15% · 11.1K
QUS.AX
0.29% · 10.2K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
100.00%
HOLDERS
945
TOP 12 OF 945 · RANKED BY POSITION SIZE
Metatron Capital Sicav Plc
50.5M sh · $979.6M
Vanguard Group Inc
5.9M sh · $1.17B
Blackrock Inc.
5.1M sh · $1.05B
Fmr LLC
4.2M sh · $961.53M
Blackrock, Inc.
3.9M sh · $665.69M
Wellington Management Group Llp
3.2M sh · $499.18M
Invesco Ltd.
3.0M sh · $676.92M
Harris Associates L P
2.2M sh · $508.27M
Allspring Global Investments Holdings, LLC
2.2M sh · $371.3M
Blackrock Fund Advisors
1.9M sh · $144.42M
State Street Corp
1.9M sh · $323.2M
Dimensional Fund Advisors LP
1.7M sh · $285M

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book2
Overall Score1

TRADES BY CONGRESS

HOUSE TRADES
Rob Bresnahan
Rob Bresnahan
Sale
2025-05-15
 Jefferson Shreve
Jefferson Shreve
Sale
2025-05-12
 Julie Johnson
Julie Johnson
Purchase
2025-01-15
 Ro Khanna
Ro Khanna
Purchase
2024-11-15

INSIDER TRADES

★
DIRECTOR
FOSTER JAMES C
Purchase · 12.4K shares
2026-08-25
★
DIRECTOR
FOSTER JAMES C
Purchase · 21.1K shares
2026-08-25
★
DIRECTOR
FOSTER JAMES C
Sale · 33.6K shares
2026-08-25
★
DIRECTOR
FOSTER JAMES C
Sale · 12.4K shares
2026-08-25

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OUTPERFORM 4
BUY 3
OVERWEIGHT 3
NEUTRAL 2
HOLD 1
13 GRADES IN THE LAST 12 MONTHS
TD Cowen BUY Morgan Stanley OVERWEIGHT RBC Capital OUTPERFORM Evercore ISI Group OUTPERFORM JP Morgan OVERWEIGHT CLSA HOLD Mizuho NEUTRAL Barclays OVERWEIGHT

SECTORS PEERS

PEERPRICE
RVTY$128.18COMPARE
BAX$26.07COMPARE
PEN$322.96COMPARE
DVA$176.44COMPARE
BIO$385.82COMPARE
AVTR$14.46COMPARE
QGEN$43.40COMPARE
CAI$25.08COMPARE